Logo

American Heart Association

  2
  0


Final ID: MDP1580

Native aortic stenosis progression: a focus on sex differences.

Abstract Body (Do not enter title and authors here): Background. Paucity of evidence is available on sex-differences in the progression, left ventricular (LV) remodelling and long-term outcome in patients with native mild-to-moderate aortic stenosis (AS) and preserved LV ejection fraction (LVEF).
Objectives. To assess the sex-differences in the progression, LV remodelling and long-term outcome of native AS.
Methods. Baseline and follow-up echocardiographic data of patients with at least mild-to-moderate AS [aortic valve area(AVA)≤1.5 cm2, maximum aortic velocity(Vmax) ≥2.5 m/s or mean gradient(MG)≥25 mmHg] were prospectively collected between 2014 and 2019 and retrospectively analysed. Patients with LVEF<50%, or mitral or aortic regurgitation >mild were excluded. AS progression (analysed by annualized progression ratios in echocardiographic parameters), all-cause death, aortic valve replacement (AVR), were investigated stratifying for sex.
Results. We included 677 patients with a mean age of 70.8±13.2 years, 258 (38.1%) women. During a median 5 years follow-up, 118(17.4%) deaths and 211(32.2%) AVR occurred. After inverse-propensity-weighting (IPW), men had faster progression rate of AS compared to women (MG: mean difference 1.77[1.10-2.43] mmHg/year, p<0.0001; and Vmax: mean difference 9.56[5.7-13.4] cm/s/year, p<0.0001). While women had higher annualized progression ratio in LV mass-indexed (mean difference 2.51[4.56-0.45] mg/m2/year, p=0.017), relative wall thickness (mean difference 0.007[0.01-0.003], p=0.039), but lower stroke-volume-indexed (SVi) (mean difference 0.80[1.10-2.43]ml/m2/year, p=0.012). Similar results were obtained after 1:1 matching. Relative to women, men presented similar incidence of all-cause mortality (HR 1.07[0.72-1.56], p=0.73) and AVR on competitive risk analysis (IPW-Sub Hazard Ratio SHR 0.93 [0.61-1.41], p=0.74).
Conclusions. Mild-to-moderate AS in men presented accentuated hemodynamic progression over time; however, women were more likely to develop LV hypertrophic/concentric remodelling accompanied by lower flow. Similar long-term outcomes were observed in men and women. These results emphasize the importance of evaluating LV remodelling and flow pattern in AS, and not only the AS severity. The slower hemodynamic progression of AS observed in women may be linked to their tendency in reducing SVi, due to distinct LV remodelling pattern.
  • Springhetti, Paolo  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Abdoun, Kathia  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Powers, Andreanne  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Tastet, Lionel  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Beaudoin, Jonathan  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Pibarot, Philippe  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Clavel, Marie-annick  ( IUCPQ-UL , Quebec , Quebec , Canada )
  • Author Disclosures:
    Paolo Springhetti: DO NOT have relevant financial relationships | Kathia Abdoun: DO NOT have relevant financial relationships | Andreanne Powers: DO NOT have relevant financial relationships | Lionel Tastet: No Answer | Jonathan Beaudoin: DO have relevant financial relationships ; Research Funding (PI or named investigator):JAMP Pharma:Active (exists now) | Philippe Pibarot: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Research Funding (PI or named investigator):Cardiac Success:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Pi-Cardia:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Marie-Annick Clavel: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Past (completed) ; Research Funding (PI or named investigator):Pi-Cardia:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Sex Differences in Aortic Stenosis Progression and Treatment, and in MVP Risk

Monday, 11/18/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts on this topic:
Aortic Valve Calcification Density Performs Better Compared to Absolute Aortic Valve Calcification in Aortic Stenosis Risk Stratification

Ahmad Syed, Zeb Irfan, Watson Hangyu, Awad Maan, Patel Kunal, Nassar Sameh, Thyagaturu Harshith, Balla Sudarshan, Kawsara Mohammad, Daggubati Ramesh

Artificial Intelligence-estimated Probability of Aortic Stenosis Is an Independent Predictor of Major Adverse Cardiac Events in Patients with Carotid Artery Disease After Carotid Endarterectomy

Mahmoudi Hamidabad Negin, Kalina Samuel, Nogami Kai, Lerman Lilach, Nardi Valentina, Lerman Amir

More abstracts from these authors:
Impact of Early Menopause and Hormonal Replacement Therapy on Aortic Stenosis Progressio

Abdoun Kathia, Tastet Lionel, Bedard Elisabeth, Arsenault Marie, Pibarot Philippe, Clavel Marie-annick

Sex difference in Prosthesis-Patient Mismatch after Surgical Aortic Valve Replacement and long-term clinical outcome

Springhetti Paolo, Abdoun Kathia, Dumont Eric, Dagenais Francois, Kalavrouziotis Dimitri, Mohammadi Siamak, Pibarot Philippe, Clavel Marie-annick

You have to be authorized to contact abstract author. Please, Login
Not Available